Drugs / ADXS31-164
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02386501 | Sep 2015 → Apr 2017 | — | Advaxis, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADXS31-164 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02386501 ↗ |